U.S. flag

An official website of the United States government

NM_002074.5(GNB1):c.230G>A (p.Gly77Asp) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 2, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001266576.5

Allele description [Variation Report for NM_002074.5(GNB1):c.230G>A (p.Gly77Asp)]

NM_002074.5(GNB1):c.230G>A (p.Gly77Asp)

Gene:
GNB1:G protein subunit beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.33
Genomic location:
Preferred name:
NM_002074.5(GNB1):c.230G>A (p.Gly77Asp)
HGVS:
  • NC_000001.11:g.1806512C>T
  • NG_047052.1:g.89606G>A
  • NM_001282538.2:c.-71G>A
  • NM_001282539.2:c.230G>A
  • NM_002074.5:c.230G>AMANE SELECT
  • NP_001269468.1:p.Gly77Asp
  • NP_002065.1:p.Gly77Asp
  • NC_000001.10:g.1737951C>T
  • NM_002074.3:c.230G>A
  • NM_002074.4:c.230G>A
Protein change:
G77D
Links:
dbSNP: rs1135401746
NCBI 1000 Genomes Browser:
rs1135401746
Molecular consequence:
  • NM_001282538.2:c.-71G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001282539.2:c.230G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002074.5:c.230G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001444752Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Jan 2, 2020)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular basis for interactions of G protein betagamma subunits with effectors.

Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, Rosal R, Weng G, Yang CS, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ, Hamm HE.

Science. 1998 May 22;280(5367):1271-4.

PubMed [citation]
PMID:
9596582

Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.

Petrovski S, Küry S, Myers CT, Anyane-Yeboa K, Cogné B, Bialer M, Xia F, Hemati P, Riviello J, Mehaffey M, Besnard T, Becraft E, Wadley A, Politi AR, Colombo S, Zhu X, Ren Z, Andrews I, Dudding-Byth T, Schneider AL, Wallace G; University of Washington Center for Mendelian Genomics, et al.

Am J Hum Genet. 2016 May 5;98(5):1001-1010. doi: 10.1016/j.ajhg.2016.03.011. Epub 2016 Apr 21.

PubMed [citation]
PMID:
27108799
PMCID:
PMC4863562
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV001444752.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The alteration results in an amino acid change:_x000D_ _x000D_ The c.230G>A (p.G77D) alteration is located in exon 6 (coding exon 4) of the GNB1 gene. This alteration results from a G to A substitution at nucleotide position 230, causing the glycine (G) at amino acid position 77 to be replaced by an aspartic acid (D). The alteration is not observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the GNB1 c.230G>A alteration was not observed, with coverage at this position. Alterations at the same codon has been observed in affected individuals:_x000D_ _x000D_ Several alterations have been described at the same codon to occur de novo in patients with a neurodevelopmental phenotype, including p.G77S, p.G77V, p.G77R, and p.G77A. All patients present with global developmental delay and hypotonia, while additional features have been reported in some including congenital defects, dystonia, eye abnormalities, acute lymphoblastic leukemia, and cutaneous mastocystosis (Brett, 2017; Hemati, 2018; Petrovski, 2016; Szcaluba, 2018). Additionally, de novo changes in neighboring amino acid residues (p.D76 and p.K78) have been reported in three additional individuals with global developmental delay, hypotonia, and epilepsy (Petrovski, 2016). The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.G77 amino acid is conserved in available vertebrate species. The amino acid is located in a functionally important protein domain:_x000D_ _x000D_ The p.G77 amino acid is located in a WD40 repeat region in the amino-terminal interface of GNB1. Crystal structures of heterotrimeric G-alpha-beta-gamma have demonstrated that this is a region of interaction between the G-protein beta subunit and alpha subunit (Ford, 1998). The adjacent p.K78 residue is reported to play an important role in regulating activation of adenylyl cyclase 2, inhibition of calcium channels, and activation of potassium channels (Ford, 1998; Petrovski, 2016). The alteration is predicted deleterious by in silico models:_x000D_ _x000D_ The p.G77D alteration is predicted to be probably damaging by Polyphen and deleterious by SIFT in silico analyses. Based on the available evidence, this alteration is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024